345 related articles for article (PubMed ID: 29463627)
1. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
Krieger EM; Drager LF; Giorgi DMA; Pereira AC; Barreto-Filho JAS; Nogueira AR; Mill JG; Lotufo PA; Amodeo C; Batista MC; Bodanese LC; Carvalho ACC; Castro I; Chaves H; Costa EAS; Feitosa GS; Franco RJS; Fuchs FD; Guimarães AC; Jardim PC; Machado CA; Magalhães ME; Mion D; Nascimento RM; Nobre F; Nóbrega AC; Ribeiro ALP; Rodrigues-Sobrinho CR; Sanjuliani AF; Teixeira MDCB; Krieger JE;
Hypertension; 2018 Apr; 71(4):681-690. PubMed ID: 29463627
[TBL] [Abstract][Full Text] [Related]
2. Resistant hypertension optimal treatment trial: a randomized controlled trial.
; Krieger EM; Drager LF; Giorgi DM; Krieger JE; Pereira AC; Barreto-Filho JA; da Rocha Nogueira A; Mill JG
Clin Cardiol; 2014 Jan; 37(1):1-6. PubMed ID: 24338935
[TBL] [Abstract][Full Text] [Related]
3. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
[TBL] [Abstract][Full Text] [Related]
4. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Kreutz R; Scholze J; Douros A
Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
[TBL] [Abstract][Full Text] [Related]
5. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
6. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
[TBL] [Abstract][Full Text] [Related]
7. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension.
Vaclavik J; Sedlak R; Jarkovsky J; Kocianova E; Taborsky M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):50-5. PubMed ID: 23128822
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
[TBL] [Abstract][Full Text] [Related]
9. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
[TBL] [Abstract][Full Text] [Related]
10. Resistant Hypertension: Time to Consider the Best Fifth Anti-Hypertensive Treatment.
Pio-Abreu A; Drager LF
Curr Hypertens Rep; 2018 Jun; 20(8):67. PubMed ID: 29909538
[TBL] [Abstract][Full Text] [Related]
11. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction.
Rossignol P; Claggett BL; Liu J; Vardeny O; Pitt B; Zannad F; Solomon S
Am J Hypertens; 2018 Mar; 31(4):407-414. PubMed ID: 29228101
[TBL] [Abstract][Full Text] [Related]
15. Blood Pressure Lowering in Patients With Central Hypertension: A Randomized Clinical Trial.
Sharman JE; Otahal P; Stowasser M; Stanton T; Reid CM; Nolan M; Roberts-Thomson P; Negishi K; Greenough R; Stewart S; Marwick TH; Abhayaratna WP
Hypertension; 2024 Jun; 81(6):1400-1409. PubMed ID: 38563148
[TBL] [Abstract][Full Text] [Related]
16. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
[TBL] [Abstract][Full Text] [Related]
18. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.
Oxlund CS; Henriksen JE; Tarnow L; Schousboe K; Gram J; Jacobsen IA
J Hypertens; 2013 Oct; 31(10):2094-102. PubMed ID: 24107738
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bariatric Surgery Versus Medical Therapy on the 24-Hour Ambulatory Blood Pressure and the Prevalence of Resistant Hypertension.
Schiavon CA; Ikeoka D; Santucci EV; Santos RN; Damiani LP; Bueno PT; Oliveira JD; Torreglosa CR; Bersch-Ferreira AC; Miranda TA; Barros S; Halpern H; Monteiro FLJ; Cohen RV; Noujaim PM; de Souza MG; Amodeo C; Bortolotto LA; Berwanger O; Cavalcanti AB; Drager LF
Hypertension; 2019 Mar; 73(3):571-577. PubMed ID: 30661477
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
